Alector (ALEC) Assets Average (2019 - 2026)
Alector (ALEC) posted quarterly Assets Average of $266.6 million for Q1 2026, down 39.18% year-over-year from $438.3 million in Q1 2025, and down 15.17% quarter-over-quarter from $314.3 million in Q4 2025.
Alector (ALEC) Assets Average (2019 - 2026) Analysis & Trends
Alector (ALEC) has reported Assets Average for 8 consecutive years, with $266.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average fell 39.18% year-over-year to $266.6 million; the TTM figure through Mar 2026 stood at $266.6 million (down 39.18% YoY), while the FY2025 annual figure was $380.8 million, down 30.14% from the prior year.
- Assets Average slipped to $266.6 million in Q1 2026 per ALEC's latest filing, from $314.3 million in the prior quarter.
- Across five years, Assets Average topped out at $922.1 million in Q2 2022 and bottomed at $266.6 million in Q1 2026.
- Historically, Assets Average has averaged $607.7 million across 5 years, with a median of $628.7 million in 2024.
- Annual changes were most pronounced in 2022 — Assets Average surged 120.2% — and 2026, when it tumbled 39.18%.
- Alector's Assets Average stood at $812.3 million in 2022, then fell by 20.34% to $647.1 million in 2023, then slipped by 23.94% to $492.2 million in 2024, then sank by 36.15% to $314.3 million in 2025, then retreated by 15.17% to $266.6 million in 2026.
- Business Quant data shows ALEC's Assets Average at $266.6 million in Q1 2026, $314.3 million in Q4 2025, and $345.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | 221.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 221.39 Mn |
| Mar 31, 2026 | 266.58 Mn |
| Dec 31, 2025 | 314.26 Mn |
| Sep 30, 2025 | 345.85 Mn |
| Jun 30, 2025 | 382.36 Mn |
| Mar 31, 2025 | 438.30 Mn |
| Dec 31, 2024 | 492.16 Mn |
| Sep 30, 2024 | 543.38 Mn |
| Jun 30, 2024 | 603.11 Mn |
| Mar 31, 2024 | 628.66 Mn |
| Dec 31, 2023 | 647.11 Mn |
| Sep 30, 2023 | 690.57 Mn |
| Jun 30, 2023 | 728.54 Mn |
| Mar 31, 2023 | 768.00 Mn |
| Dec 31, 2022 | 812.34 Mn |
| Sep 30, 2022 | 863.36 Mn |
| Jun 30, 2022 | 922.06 Mn |
| Mar 31, 2022 | 884.56 Mn |
| Dec 31, 2021 | 834.44 Mn |
| Sep 30, 2021 | 625.67 Mn |